Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Hypothesis-free detection of gene-interaction effects on biomarker concentration in UK Biobank using variance prioritisation

View ORCID ProfileMatthew S. Lyon, Louise A. C. Millard, George Davey Smith, Tom R. Gaunt, Kate Tilling
doi: https://doi.org/10.1101/2022.01.05.21268406
Matthew S. Lyon
1National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
2Medical Research Council (MRC) Integrative Epidemiology Unit (IEU), Bristol Medical School (Population Health Sciences), University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew S. Lyon
  • For correspondence: matt.lyon{at}bristol.ac.uk
Louise A. C. Millard
2Medical Research Council (MRC) Integrative Epidemiology Unit (IEU), Bristol Medical School (Population Health Sciences), University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Davey Smith
1National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
2Medical Research Council (MRC) Integrative Epidemiology Unit (IEU), Bristol Medical School (Population Health Sciences), University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom R. Gaunt
1National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
2Medical Research Council (MRC) Integrative Epidemiology Unit (IEU), Bristol Medical School (Population Health Sciences), University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate Tilling
1National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
2Medical Research Council (MRC) Integrative Epidemiology Unit (IEU), Bristol Medical School (Population Health Sciences), University of Bristol, Oakfield House, Bristol, BS8 2BN, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Blood biomarkers include disease intervention targets that may interact with genetic and environmental factors resulting in subgroups of individuals who respond differently to treatment. Such interactions may be observed in genetic effects on trait variance. Variance prioritisation is an approach to identify genetic loci with interaction effects by estimating their association with trait variance, even where the modifier is unknown or unmeasured. Here, we develop and evaluate a regression-based Brown-Forsythe test and variance effect estimate to detect such interactions. We provide scalable open-source software (varGWAS) for genome-wide association analysis of SNP-variance effects (https://github.com/MRCIEU/varGWAS) and apply our software to 30 blood biomarkers in UK Biobank. We find 468 variance quantitative trait loci across 24 biomarkers and follow up findings to detect 82 gene-environment and six gene-gene interactions independent of strong scale or phantom effects. Our results replicate existing findings and identify novel epistatic effects of TREH rs12225548 x FUT2 rs281379 and TREH rs12225548 x ABO rs635634 on alkaline phosphatase and ZNF827 rs4835265 x NEDD4L rs4503880 on gamma glutamyltransferase. These data could be used to discover possible subgroup effects for a given biomarker during preclinical drug development.

Competing Interest Statement

T.R.G receives funding from Biogen for unrelated research. K.T has been paid for consultancy for CHDI.

Funding Statement

This study was funded by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. This work was also funded by the UK Medical Research Council as part of the MRC Integrative Epidemiology Unit (MC_UU_00011/1, MC_UU_00011/3 and MC_UU_00011/4).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval for the UK Biobank study was granted by the National Research Ethics Service (NRES) Committee North West (ref 11/NW/0382). All analyses were performed under approved UK Biobank project 15825 (dataset ID 33352).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Software to perform variance GWAS using the LAD Brown-Forsythe model is available from https://github.com/MRCIEU/varGWAS and R-package for ad hoc analyses is available from https://github.com/MRCIEU/varGWASR. Code for performing simulation studies is available from https://github.com/MRCIEU/varGWAS/sim. Code for running the UK Biobank analysis is available from https://github.com/MRCIEU/varGWAS-ukbb-biomarkers. Full variance GWAS summary statistics are available from the OpenGWAS project. All code repositories are available under the GPL v3 license.

https://github.com/MRCIEU/varGWAS

https://github.com/MRCIEU/varGWASR

https://github.com/MRCIEU/varGWAS-ukbb-biomarkers

https://gwas.mrcieu.ac.uk/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 05, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Hypothesis-free detection of gene-interaction effects on biomarker concentration in UK Biobank using variance prioritisation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Hypothesis-free detection of gene-interaction effects on biomarker concentration in UK Biobank using variance prioritisation
Matthew S. Lyon, Louise A. C. Millard, George Davey Smith, Tom R. Gaunt, Kate Tilling
medRxiv 2022.01.05.21268406; doi: https://doi.org/10.1101/2022.01.05.21268406
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Hypothesis-free detection of gene-interaction effects on biomarker concentration in UK Biobank using variance prioritisation
Matthew S. Lyon, Louise A. C. Millard, George Davey Smith, Tom R. Gaunt, Kate Tilling
medRxiv 2022.01.05.21268406; doi: https://doi.org/10.1101/2022.01.05.21268406

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)